急性リンパ性白血病の患者におけるCAR T細胞療法:体系的なレビューとメタ解析
Victor Navarro1, Gloria Iacoboni2,3, Sergi Camarillas2
1Statistics unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Bone marrow transplantation
|February 14, 2026
まとめ
化学抗原受容体 (CAR) T細胞療法では,再発/耐性B細胞急性リンパ性白血病の寛解率が高いことが示されています. CD19を標的にする4-1BB CAR T細胞構造は,より優れた有効性と安全性を実証し,持続的な応答を改善しています.
科学分野:
- 血液学 ヘマトロジ
- 免疫療法による免疫療法です.
- 腫瘍学 腫瘍学
背景:
- 化学抗原受容体 (CAR) T細胞治療は,リラクゼーション/リフラクタリー (R/R) B細胞急性リンパ性白血病 (B-ALL) 治療に変化をもたらしました.
- 応答の持続性は重要な課題であり,初期寛解後の再発が頻発しています.
研究 の 目的:
- R/R B-ALLにおける様々なCAR T細胞構造の有効性と安全性を体系的にレビューし,メタ分析する.
- 患者の人口統計,以前の治療の影響を評価し,アウトカムに関する特性を構築する.
主な方法:
- 40件の臨床試験の体系的レビューとメタ解析.
- R/R B-ALLの患者1540人を含む.
- 完全寛解率 (CRR) と最小残留病陰性完全寛解率 (MRDneg-CR/CRi) の評価.
主要な成果:
- プーリングされたCRRは83.4%であり,プーリングされたMRDネガティブCR/CRiレートは92.7%であった.
- 4-1BB共刺激ドメイン構造は,より高いMRD-neg-CR/CRi率 (94.0%) をCD28 (84.4%) と比較し,神経毒性イベントが少なくなった.
- CD19またはCD19/CD22を標的としたCAR T細胞は,CD22を標的とした治療法と比較して,MRD-neg-CR/CRi比率が優れていることを示した.
結論:
- CD19を標的とした4-1BBベースのCAR T細胞療法では,R/R B-ALL.に対する最適な有効性および安全性プロファイルを示しています.
- CAR T細胞構造の最適化は,持続的な反応と患者の成果を向上させる上で極めて重要です.
関連する概念動画
Review and Preview
8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview
11.6K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
Random and Systematic Errors
15.4K
Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
15.4K
Directing Effect of Substituents: meta-Directing Groups
6.1K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.1K
Systematic Sampling Method
13.4K
Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
Systematic sampling is one of the simplest methods...
Systematic sampling is one of the simplest methods...
13.4K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K


